22nd Century Announces the Immediate Feasibility of the FDA’s Nicotine Reduction Plan
Business Wire India 22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is a leader in tobacco harm reduction and Very Low Nicotine tobacco, yesterday responded to the